OverviewChartNewsTraderScreen

UniCredit Call 1275 LLY 17.06.202.../  DE000HD4PE98  /

Frankfurt Zert./HVB
2024-05-31  7:31:16 PM Chg.-0.110 Bid9:59:42 PM Ask9:59:42 PM Underlying Strike price Expiration date Option type
5.270EUR -2.04% 5.430
Bid Size: 4,000		 5.640
Ask Size: 4,000		 ELI LILLY 1,275.00 - 2026-06-17 Call
GlobeNewswire 05-30 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 05-30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 05-24 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 05-24 Eli Lilly to reveal $5.3B production boost
GlobeNewswire 05-23 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit
GlobeNewswire 05-23 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit
GlobeNewswire 05-23 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
TeleTrader 05-21 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 05-16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 05-16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 05-16 HEPHAISTOS secures €10.3 M to reach the clinical stage
GlobeNewswire 05-15 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire 05-13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire 05-09 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 05-09 Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...
GlobeNewswire 05-09 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 05-08 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 05-08 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
GlobeNewswire 05-08 ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting...
GlobeNewswire 05-08 Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
GlobeNewswire 05-03 BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...
GlobeNewswire 05-01 H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
GlobeNewswire 04-30 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
TeleTrader 04-30 Eli Lilly's Q1 revenue surges 26% to $8.8B